Spine

First Implantations with MOVE-C Cervical Disc Prostheses from NGMedical, Germany

February 05, 2020 

NONNWEILER, Germany–(BUSINESS WIRE)–NGMedical GmbH informs about the worldwide first implantations of its new MOVE-C disc prosthesis. After receiving CE approval end of December 2019, the first MOVE-C cervical disc prostheses were implanted in January. The well thought through instrument set and the anatomical design of MOVE-C were crucial for the smooth surgeries. MOVE-C combines the features of a second generation disc prosthesis with the simple implantation technique of a cervical cage. The prosthesis offers physiological motion in all 6 planes including axial damping with progressive resistance to motion. Furthermore, MOVE-C is the first prosthesis with additively manufactured titanium endplates and avoids the use of PE.

NGMedical is specialized in motion preserving spinal implants as well as intelligent solutions for fusion surgery. With an experienced team of specialists and in cooperation with experienced spine surgeons NGMedical works on well thought through and tested solutions for state of the art spine surgery. In the near future, the new cervical BEE cage with a sophisticated honeycomb structure, which is purely manufactured additively, will be available.

For more information www.ngmedical.de

Contacts

Peter Weiland
pweiland@ngmedical.de
Tel: +49 6873 999970

Print Friendly, PDF & Email
Tags

Chris J. Stewart

Chris currently serves as Chief Executive Officer of Surgio Health as well as COO at Ortho Spine Partners. Chris has close to 20 years of healthcare management experience with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that solve real problems that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help drive better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button
Close